Skip to content

Collagen Matrix in Oral Cancer Surgery

Postoperative Swallowing and Voice Outcomes After Collagen Matrix Reconstruction in Oral and Oropharyngeal Cancer Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07337122
Enrollment
33
Registered
2026-01-13
Start date
2020-11-16
Completion date
2025-03-31
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer, Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma

Keywords

oral cancer, phonation, swallowing, voice, glossectomy, reconstruction, tachosil

Brief summary

This study tend to evaluate postoperative phonation and swallowing after oncologic surgery of the oral cavity or oropharynx with application of a collagen matrix (Tachosil®). Patients are asked to complete a questionnaire the day before the surgery and at 1 and 6 months after.

Detailed description

It was an interventional study with a single Group.

Interventions

None listed

Sponsors

SAYAH Charline
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Histologically confirmed squamous cell carcinoma or other malignant tumor of the oral cavity and/or oropharynx * Performance status (PS) 0-2 * Tumor stages for which surgical resection was indicated (T1-T3) * Patients receiving or not receiving postoperative adjuvant radiotherapy

Exclusion criteria

* Legal incapacity or limited legal capacity * Inability or anticipated poor compliance with study procedures * Missing questionnaire data * Congenital or acquired swallowing disorders (neurological or neuromuscular disease) * Congenital or acquired speech disorders (neurological or neuromuscular disease) * Death during the study period

Design outcomes

Primary

MeasureTime frameDescription
Swallowing evaluationFrom enrollment (the day before the surgery) to 6 months postoperatively.We use the Deglutition Handicap Index questionnaire to evaluative swallowing before and after surgery. Patients completed the questionnaires the day before surgery, and at 1 month and 6 months postoperatively.
Voice evaluationFrom enrollment (the day before the surgery) to 6 months postoperatively.We use the Voice Handicap Index questionnaire to evaluate the phonatione before and after surgery. Patients completed the questionnaires the day before surgery, and at 1 month and 6 months postoperatively.

Secondary

MeasureTime frameDescription
Length of hospital stayFrom the day before the surgery up to 3 weeks after surgery. The number of days between hospital admission and discharge to home was calculated.We evaluate the length of hospital stay, it was expressed in days as mean and standard deviation
time to oral feeding resumptionFrom the surgery up to two weeks.Number of days between the surgery and the time the patient start to eat again by the mouth.
incidence and onset of device-related complicationsFrom the day of the surgery to one week afterIncidence of immunologic reaction to the collagen matrix (tachosil). Expressed in number and pourcentage.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026